WO1999019491A3 - Interleukine-40 adnx humaine (dil-40) - Google Patents

Interleukine-40 adnx humaine (dil-40) Download PDF

Info

Publication number
WO1999019491A3
WO1999019491A3 PCT/US1998/020932 US9820932W WO9919491A3 WO 1999019491 A3 WO1999019491 A3 WO 1999019491A3 US 9820932 W US9820932 W US 9820932W WO 9919491 A3 WO9919491 A3 WO 9919491A3
Authority
WO
WIPO (PCT)
Prior art keywords
dil
human dnax
interleukin
dnax interleukin
human
Prior art date
Application number
PCT/US1998/020932
Other languages
English (en)
Other versions
WO1999019491A2 (fr
Inventor
J Fernando Bazan
Robert A Kastelein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to AU97863/98A priority Critical patent/AU9786398A/en
Publication of WO1999019491A2 publication Critical patent/WO1999019491A2/fr
Publication of WO1999019491A3 publication Critical patent/WO1999019491A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

L'invention concerne des gènes purifiés codant des cytokines d'un mammalien, des réactifs afférents comprenant des polypeptides purifiés, des anticorps spécifiques et des acides nucléiques codant cette molécule. L'invention concerne également des méthodes d'utilisation de ces réactifs ainsi que des trousses de diagnostic.
PCT/US1998/020932 1997-10-14 1998-10-13 Interleukine-40 adnx humaine (dil-40) WO1999019491A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU97863/98A AU9786398A (en) 1997-10-14 1998-10-13 Human dnax interleukin-40 (dil-40)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95023897A 1997-10-14 1997-10-14
US08/950,238 1997-10-14

Publications (2)

Publication Number Publication Date
WO1999019491A2 WO1999019491A2 (fr) 1999-04-22
WO1999019491A3 true WO1999019491A3 (fr) 1999-07-01

Family

ID=25490146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/020932 WO1999019491A2 (fr) 1997-10-14 1998-10-13 Interleukine-40 adnx humaine (dil-40)

Country Status (4)

Country Link
AR (1) AR016145A1 (fr)
AU (1) AU9786398A (fr)
WO (1) WO1999019491A2 (fr)
ZA (1) ZA989343B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6383700A (en) * 1999-07-30 2001-02-19 Schering Corporation Mammalian cytokines; related reagents
US7148330B2 (en) 1999-07-30 2006-12-12 Schering Corporation Binding compounds for IL-27
DK2271342T3 (da) 2008-03-28 2012-10-29 Elanco Animal Health Ireland Anvendelse af nicotinamid til behandling af sommereksem hos heste

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
N.Y. IP ET AL: "The neurotrophins and CNTF: Two families of collaborative neurotrophic factors", ANNUAL REVIEW OF NEUROSCIENCE, vol. 19, 1996, pages 491 - 515, XP002096172 *

Also Published As

Publication number Publication date
AR016145A1 (es) 2001-06-20
ZA989343B (en) 2000-04-13
WO1999019491A2 (fr) 1999-04-22
AU9786398A (en) 1999-05-03

Similar Documents

Publication Publication Date Title
EP2100959A3 (fr) Cytokine de mammifères: interleukine-B30 et réactifs apparentés
WO1995018826A3 (fr) Antigenes a ctla-8 de primates purifiee et reactifs correspondants
WO1998027114A3 (fr) Antigenes de surface mammaliens et reactifs associes
CA2263129A1 (fr) Antigenes de surface de cellules mammaliennes et reactifs qui y sont lies
WO1997021812A3 (fr) Chemokine mammifere ccf8 et recepteur de chemokine cckr3
LU91756I2 (fr) Denosumab
EP1897949A3 (fr) Utilisations thérapeutiques d'interleukine-B50 humaine
WO2000042188A3 (fr) Cytokines de mammiferes liees a l'interleukin-17, polynucleotides les codant et leurs utilisations
WO1998001557A3 (fr) Reactifs apparentes a des chemokines mammaliennes
EP1942114A3 (fr) "Cytokines de mammifères ; réactifs et procédés associés"
WO1998011226A3 (fr) Chemokines de mammiferes et reactifs apparentes
WO1998024906A3 (fr) Genes isoles de monocytes de mammifere et reactifs associes
AU1825097A (en) Mammalian cx3c chemokine genes
WO1999003993A3 (fr) Suppresseurs de signalement de cytokine et reactifs correspondants
WO1998039421A3 (fr) Proteinase mammaliennes, oxydoreductase, proteines de liaison avec gtp et reactifs correspondants
WO1998023750A3 (fr) Chemokines de mammiferes
WO1998032858A3 (fr) Chemokines de mammiferes, recepteurs, reactifs, et modes d'utilisation
WO2003020005A3 (fr) Proteines de mammiferes lp et reactifs associes
DE69534178D1 (en) S?ugetier thymokingene
WO2002068596A3 (fr) Cytokines de mammifere, reactifs associes
WO1998031810A3 (fr) Chemokines de mammiferes, recepteurs, reactifs, utilisations
WO1999019491A3 (fr) Interleukine-40 adnx humaine (dil-40)
WO1999047673A3 (fr) Genes de proteines membranaires mammiferes isoles, et reactifs associes
WO2002074906A3 (fr) Proteines de mammiferes lp et reactifs associes
WO2001009176A3 (fr) Cytokines mammaliennes; reactifs correspondants

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GD GE HR HU ID IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GD GE HR HU ID IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA